4.2 Article

A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naive genotype 1 hepatitis C patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing

Einar Bjornsson et al.

JOURNAL OF HEPATOLOGY (2012)

Editorial Material Gastroenterology & Hepatology

The Myth of Statin-Induced Hepatotoxicity

Ted Bader

AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)

Letter Gastroenterology & Hepatology

Statins Improve ALT Values in Chronic Hepatitis C Patients with Abnormal Values

Mohammad F. Madhoun et al.

DIGESTIVE DISEASES AND SCIENCES (2010)

Article Gastroenterology & Hepatology

Serum Cholesterol and Statin Use Predict Virological Response to Peginterferon and Ribavirin Therapy

Stephen A. Harrison et al.

HEPATOLOGY (2010)

Meeting Abstract Gastroenterology & Hepatology

ROSUVASTATIN COMPARED TO FLUVASTATIN, SIMVASTATIN, AND RIBAVIRIN FOR ANTI-HCV ACTIVITY IN VITRO

T. Bader et al.

JOURNAL OF HEPATOLOGY (2010)

Editorial Material Medicine, General & Internal

Liver tests are irrelevant when prescribing statins

Ted Bader

LANCET (2010)

Article Gastroenterology & Hepatology

Fluvastatin inhibits hepatitis C replication in humans

Ted Bader et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)

Article Gastroenterology & Hepatology

Different anti-HCV profiles of statins and their potential for combination therapy with interferon

Masanori Ikeda et al.

HEPATOLOGY (2006)

Article Gastroenterology & Hepatology

Antiviral action of ribavirin in chronic hepatitis C

JM Pawlotsky et al.

GASTROENTEROLOGY (2004)

Article Multidisciplinary Sciences

Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation

J Ye et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)